Loading clinical trials...
Loading clinical trials...
Testing the Potential Effect of a Potassium-rich Water Intervention on Blood Pressure in Mild to Moderately Hypertensive Adults: a Double-blind Randomised Controlled Trial
The aim of this study is to conduct a definitive trial to assess the efficacy of consuming 1L/day of water rich in potassium to reduce blood pressure in mild to moderately hypertensive adults. The objective is to assess the potential effect of the intervention on reducing systolic blood pressure. This study will comprise of a 4 week, double-blind, parallel randomised controlled trial. Participants will be adults with systolic blood pressure measurements of 130mmHg or greater. The intervention comprises advice to consume bottled water rich in potassium. The comparator will be regular bottled mineral water.This study will recruit 40 people with elevated systolic blood pressure (≥130mmHg) who are not regularly taking antihypertensive medication.
Age
20 - 64 years
Sex
ALL
Healthy Volunteers
No
Oxford Brookes University
Oxford, Oxfordshire, United Kingdom
Start Date
July 30, 2022
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
April 4, 2024
40
ACTUAL participants
High potassium water
DIETARY_SUPPLEMENT
Control low potassium water
DIETARY_SUPPLEMENT
Lead Sponsor
Oxford Brookes University
Collaborators
NCT06669715
NCT06656130
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06350604